Zobrazeno 81 - 90
of 414
pro vyhledávání: '"Yutaka Miura"'
Autor:
Ming Wang, Yuki Mochida, Yutaka Miura, Kenji Tsuchihashi, Hideyuki Saya, Jun Makino, Kazunori Kataoka, Nobuhiro Nishiyama, Osamu Nagano, Kazuki Miyano, Ami Tanabe, Horacio Cabral, Momoko Yoshikawa
Publikováno v:
Journal of Controlled Release. 230:26-33
Eventual relapse of tumor growth is commonly observed in head and neck cancer patients, following treatment with platinum-based chemotherapies. This occurrence is believed to be related to the failure to eradicate drug resistant, cancer stem cell (CS
Autor:
Kazunori Kataoka, Horacio Cabral, Hiroaki Kinoh, Tsukasa Chida, Xueying Liu, Kazue Mizuno, Yosuke Morodomi, Yutaka Miura, Shigeto Fukushima, Nobuhiro Nishiyama
Publikováno v:
ACS Nano. 10:5643-5655
Nanomedicines capable of control over drug functions have potential for developing resilient therapies, even against tumors harboring recalcitrant cancer stem cells (CSCs). By coordinating drug interactions within the confined inner compartment of co
Autor:
Yutaka Miura, Omer Faruk Mutaf, Takehiko Ishii, Nobuhiro Nishiyama, Kazunori Kataoka, Ahram Kim, Horacio Cabral
Publikováno v:
Biomacromolecules. 17:446-453
Direct intracellular delivery of antibodies has gained much attention, although only a few agents have been developed, and none of them has reached clinical stages. The main obstacles here are the insufficient characteristics of delivery systems incl
Publikováno v:
Joho Chishiki Gakkaishi. 26:174-179
Autor:
Kyoko Tazumi, Yutaka Miura, Takayoshi Kirisako, Hajime Nozawa, Takeshi Kokubo, Shyuichi Maeda
Publikováno v:
Preventive Nutrition and Food Science. 20:238-245
A non-protein amino acid, L-ornithine (Orn), has been shown to stimulate the urea cycle and tissue protein synthesis in the liver. The purpose of the current study was to assess whether Orn affects the mammalian target of rapamycin (mTOR) complex 1 (
Autor:
Yoshinori Maeda, Kanjiro Miyata, Nobuhiro Nishiyama, Hyun Jin Kim, Mitsuru Naito, Ryota Azuma, Jooyeon Ahn, Montira Tangsangasaksri, Kazunori Kataoka, Hiroyasu Takemoto, Daiki Sueyoshi, Yutaka Miura
Publikováno v:
Biomacromolecules. 17:246-255
Small interfering RNA (siRNA) needs an efficient delivery vehicle to reach the cytoplasm of target cells for successful RNA interference (RNAi) therapy. This study aimed to develop an siRNA-loaded polyion complex (PIC) micelle equipped with a smart p
Autor:
Yutaka Miura
Publikováno v:
LASE Journal of Sport Science. 6:77-91
At this time of rapid change in society, what kind of educational role must the physical education curriculum and sports instruction play? As a matter of course, the teacher assesses the ability of the students as a specialized leader of sports and m
Autor:
Hitomi Sudo, Atsushi B. Tsuji, Kosei Hirakawa, Nobuhiro Nishiyama, Masayuki Inubushi, Masakazu Yashiro, Horacio Cabral, Kazunori Kataoka, Aya Sugyo, Ichio Aoki, Yutaka Miura, Tsuneo Saga
Publikováno v:
ACS Biomaterials Science & Engineering. 1(11):1067-1076
Scirrhous gastric cancer (SGC) is a recalcitrant tumor, which is among the most lethal cancers. A critical issue for the improvement of SGC prognosis is the lack of an effective imaging method for accurate detection and diagnosis. Because combined nu
Autor:
Yoshihiro Hayakawa, Horacio Cabral, Sabina Quader, Tatsuro Irimura, Yutaka Miura, Kazunori Kataoka, John D. Martin, Hailiang Wu, Louise Hespel, Kei Takahashi, Anqi Tao, Xueying Liu
Publikováno v:
Journal of Pharmaceutical Sciences
Journal of Pharmaceutical Sciences, Wiley, 2017, 106 (9), pp.2438-2446. ⟨10.1016/j.xphs.2017.03.031⟩
Journal of Pharmaceutical Sciences, Wiley, 2017, 106 (9), pp.2438-2446. ⟨10.1016/j.xphs.2017.03.031⟩
Macrophage reprogramming toward a tumor-attacking phenotype is a promising treatment strategy, yet such strategies are scarce and it is not clear how to combine them with cytotoxic therapies that are often used to treat solid tumors. Here, we evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0abb0f1c88806667652d092605ddaf
https://hal.archives-ouvertes.fr/hal-02301424
https://hal.archives-ouvertes.fr/hal-02301424
Autor:
Yutaka Miura, Masahiro Yasunaga, Yoshikatsu Koga, Ryuta Sato, Horacio Cabral, Nobuhiro Nishiyama, Ahram Kim, Naoki Yamada, Kazunori Kataoka, Jooyeon Ahn, Yasuhiro Matsumura, Ryo Tsumura, Xueying Liu, Tsukasa Chida
Publikováno v:
Biomaterials. 39:23-30
Antibody-mediated therapies including antibody-drug conjugates (ADCs) have shown much potential in cancer treatment by tumor-targeted delivery of cytotoxic drugs. However, there is a limitation of payloads that can be delivered by ADCs. Integration o